Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

CINGW

Cingulate (CINGW)

Cingulate Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CINGW
日付受信時刻ニュースソース見出しコード企業名
2024/06/1408 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
2024/06/1408 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
2024/06/1408 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
2024/06/1408 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
2024/06/1408 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
2024/06/1408 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
2024/06/1408 : 59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CINGWCingulate Inc
2024/06/1306 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
2024/06/0807 : 00Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CINGWCingulate Inc
2024/05/2906 : 54Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CINGWCingulate Inc
2024/05/2822 : 20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
2024/05/2413 : 15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CINGWCingulate Inc
2024/05/2406 : 01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CINGWCingulate Inc
2024/05/2122 : 00GlobeNewswire Inc.FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHDNASDAQ:CINGWCingulate Inc
2024/05/1806 : 01Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:CINGWCingulate Inc
2024/05/1321 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
2024/05/0820 : 15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CINGWCingulate Inc
2024/05/0820 : 10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CINGWCingulate Inc
2024/05/0820 : 00GlobeNewswire Inc.Cingulate Reports First Quarter 2024 Financial Results and Provides Clinical and Business UpdateNASDAQ:CINGWCingulate Inc
2024/04/3018 : 45GlobeNewswire Inc.Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live AccessNASDAQ:CINGWCingulate Inc
2024/04/1706 : 00GlobeNewswire Inc.Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024NASDAQ:CINGWCingulate Inc
2024/04/0121 : 00GlobeNewswire Inc.Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business UpdateNASDAQ:CINGWCingulate Inc
2024/03/2005 : 45GlobeNewswire Inc.Cingulate to Participate in Benzinga All Live Access EventNASDAQ:CINGWCingulate Inc
2024/03/0620 : 45GlobeNewswire Inc.Cingulate to Attend DCAT Week 2024 in New York CityNASDAQ:CINGWCingulate Inc
2024/02/1320 : 45GlobeNewswire Inc.Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of DirectorsNASDAQ:CINGWCingulate Inc
2024/02/0706 : 15GlobeNewswire Inc.Cingulate Announces Closing of $7.5 Million Public OfferingNASDAQ:CINGWCingulate Inc
2024/02/0223 : 15GlobeNewswire Inc.Cingulate Announces Pricing of $7.5 Million Public OfferingNASDAQ:CINGWCingulate Inc
2024/01/2922 : 00GlobeNewswire Inc.Longtime Cingulate Controller Jennifer Callahan Promoted to CFONASDAQ:CINGWCingulate Inc
2024/01/2920 : 45GlobeNewswire Inc.Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to MarketNASDAQ:CINGWCingulate Inc
2023/12/0123 : 00GlobeNewswire Inc.Cingulate Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103 (buspirone)NASDAQ:CINGWCingulate Inc
 Showing the most relevant articles for your search:NASDAQ:CINGW

最近閲覧した銘柄

Delayed Upgrade Clock